70
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Efficacy and safety of cord blood-derived dendritic cells plus cytokine-induced killer cells combined with chemotherapy in the treatment of patients with advanced gastric cancer: a randomized Phase II study

, , , , &
Pages 4617-4627 | Published online: 25 Jul 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Yan Liu, Zhong Zheng, Qixin Zhang, Xinling Zhou, Yikuan Feng & Anquan Yan. (2017) FOLFOX regimen plus dendritic cells–cytokine-induced killer cells immunotherapy for the treatment of colorectal cancer: a meta-analysis. OncoTargets and Therapy 10, pages 2621-2633.
Read now
Yan Liu, Ying Mu, Anqi Zhang, Shaoda Ren, Weihua Wang, Jiaping Xie, Yingxin Zhang & Changhui Zhou. (2017) Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer in China: a meta-analysis. OncoTargets and Therapy 10, pages 1897-1908.
Read now

Articles from other publishers (10)

Hieu Trong Ngo, Vy Thanh Dang, Nguyen Ho-Thao Nguyen, Anh Nguyen-Tu Bui & Phuc Van Pham. (2022) Comparison of cytotoxic potency between freshly cultured and freshly thawed cytokine-induced killer cells from human umbilical cord blood. Cell and Tissue Banking 24:1, pages 139-152.
Crossref
Zhipeng Zhang, Ningning Liu & Mingyu Sun. (2023) Research Progress of Immunotherapy for Gastric Cancer. Technology in Cancer Research & Treatment 22, pages 153303382211505.
Crossref
Guiyuan Liu, Dehu Chen, Xiaojun Zhao, Xiaolan You, Chuanjiang Huang, Zhiyi Cheng, Xunan Mao & Haihua Zhou. (2022) Efficacy of DC-CIK Immunotherapy Combined with Chemotherapy on Locally Advanced Gastric Cancer. Journal of Oncology 2022, pages 1-6.
Crossref
Ling Ni. (2022) Advances in Human Dendritic Cell-Based Immunotherapy Against Gastrointestinal Cancer. Frontiers in Immunology 13.
Crossref
Elnaz Faghfuri, Mahdi Abdoli Shadbad, Amir Hossein Faghfouri & Narges Soozangar. (2022) Cellular immunotherapy in gastric cancer: adoptive cell therapy and dendritic cell-based vaccination. Immunotherapy 14:6, pages 475-488.
Crossref
Barbara Mandriani, Eleonora Pelle'Gaetano Pezzicoli, Jonathan Strosberg, Daniel Abate-Daga, Attilio Guarini, Mauro Cives & Camillo Porta. (2021) Adoptive T-cell immunotherapy in digestive tract malignancies: Current challenges and future perspectives. Cancer Treatment Reviews 100, pages 102288.
Crossref
Hansong Du, Jia Yang & Ying Zhang. (2020) Cytokine-induced killer cell/dendritic cell combined with cytokine-induced killer cell immunotherapy for treating advanced gastrointestinal cancer. BMC Cancer 20:1.
Crossref
Guoming Hu, Kefang Zhong, Songxiang Wang, Shimin Wang, Qiannan Ding, Feng Xu, Wei Chen, Pu Cheng & Liming Huang. (2020) Cellular immunotherapy plus chemotherapy ameliorates survival in gastric cancer patients: a meta-analysis. International Journal of Clinical Oncology 25:10, pages 1747-1756.
Crossref
Yan Liu, Changchun Zhou, Kai Zhang, Yikuan Feng & Ruihua Zhang. (2018) The combination of apatinib and S-1 for the treatment of advanced gastric cancer in China. Medicine 97:47, pages e13259.
Crossref
Lei Zhang, Ying Mu, Anqi Zhang, Jiaping Xie, Shuangfeng Chen, Fang Xu, Weihua Wang, Yingxin Zhang, Shaoda Ren & Changhui Zhou. (2017) Cytokine-induced killer cells/dendritic cells-cytokine induced killer cells immunotherapy combined with chemotherapy for treatment of colorectal cancer in China: a meta-analysis of 29 trials involving 2,610 patients. Oncotarget 8:28, pages 45164-45177.
Crossref